Interaction of drugs with the cyclic nucleotide generating enzymes in the central nervous system.
D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000032:analysis*; D000818:Animals; D002352:Carrier Proteins / Q000494:pharmacology; D002490:Central Nervous System / Q000201:enzymology*; D002373:Cyclic AMP Receptor Protein; D006152:Cyclic GMP / Q000096:biosynthesis; D019204:GTP-Binding Proteins / Q000502:physiology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D018377:Neurotransmitter Agents / Q000494:pharmacology; D009712:Nucleotides, Cyclic / Q000096:biosynthesis*; D011956:Receptors, Cell Surface / Q000378:metabolism
D000067956:Adenylyl Cyclase Inhibitors; D002352:Carrier Proteins; D002373:Cyclic AMP Receptor Protein; D006728:Hormones; D018377:Neurotransmitter Agents; D009712:Nucleotides, Cyclic; D011956:Receptors, Cell Surface; D006160:Guanosine Triphosphate; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D006152:Cyclic GMP